Skip to main content
. Author manuscript; available in PMC: 2020 Aug 25.
Published in final edited form as: Clin Cancer Res. 2017 Nov 7;24(3):600–607. doi: 10.1158/1078-0432.CCR-17-1573

Figure 6.

Figure 6.

BAP1 expression is associated with disease-free survival in TCGA head and neck cancer cohort. Patients are grouped by tertiles of BAP1 expression, with the highest tertile (high BAP1 expression) having the poorest disease-free survival.